STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 95 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $125,000 | -92.9% | 11,802 | -93.6% | 0.00% | -100.0% |
| Q4 2018 | $1,761,000 | -38.0% | 185,395 | +8.3% | 0.00% | 0.0% |
| Q3 2018 | $2,841,000 | -0.4% | 171,120 | -3.7% | 0.00% | 0.0% |
| Q2 2018 | $2,853,000 | -14.1% | 177,731 | -18.1% | 0.00% | 0.0% |
| Q1 2018 | $3,322,000 | -1.9% | 217,129 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $3,387,000 | +39.2% | 217,129 | -1.0% | 0.00% | 0.0% |
| Q3 2017 | $2,434,000 | +119.7% | 219,252 | +82.0% | 0.00% | 0.0% |
| Q2 2017 | $1,108,000 | +88.1% | 120,477 | +74.9% | 0.00% | – |
| Q1 2017 | $589,000 | -30.9% | 68,899 | -13.6% | 0.00% | – |
| Q4 2016 | $853,000 | -3.7% | 79,719 | -2.6% | 0.00% | – |
| Q3 2016 | $886,000 | +281.9% | 81,819 | +138.3% | 0.00% | – |
| Q2 2016 | $232,000 | +241.2% | 34,337 | +133.9% | 0.00% | – |
| Q1 2016 | $68,000 | – | 14,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 579,800 | $7,224,000 | 1.01% |
| VHCP Management, LLC | 71,000 | $884,000 | 0.40% |
| Healthcare Value Capital, LLC | 16,464 | $205,000 | 0.20% |
| CARL DOMINO INC | 22,196 | $277,000 | 0.15% |
| TFS CAPITAL LLC | 120,112 | $1,497,000 | 0.13% |
| Private Capital Advisors, Inc. | 31,064 | $387,000 | 0.12% |
| Artal Group S.A. | 170,000 | $2,118,000 | 0.08% |
| TimesSquare Capital Management, LLC | 801,225 | $9,983,000 | 0.06% |
| Baker Brothers Advisors | 338,671 | $4,220,000 | 0.05% |
| STONERIDGE INVESTMENT PARTNERS LLC | 19,399 | $242,000 | 0.04% |